.Invite to this week's Chutes & Ladders, our roundup of considerable leadership hirings, firings ...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the openin...
.AbbVie has actually gone back to the resource of its antipsychotic goliath Vraylar searching for on...
.GenSight Biologics is full weeks away from lacking cash. Once more. The biotech merely possesses ad...
.Monopar Therapeutics is actually recovering a medicine from the scrap heap of AstraZeneca's rare di...
.Along with brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of ...
.After forming a genetics therapy alliance with Dyno Rehabs in 2020, Roche is actually back for addi...
.Lundbeck is slashing the book value of its $250 thousand Abide Therapies buyout in response to peri...
.The assimilation of real-world information (RWD) in to protocol feasibility and site choice has act...
.At this year's Intense Biotech Peak in Boston, our experts overtook forerunners in the biotech mark...